Focus Taiwan App
Download

WHO-led clinical trial of Medigen COVID-19 vaccine to be unblinded

02/15/2022 10:07 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

The Taiwanese vaccine maker, Medigen Vaccine Biologics Corp., said Tuesday that a World Health Organization-led (WHO) clinical trial of its COVID-19 vaccine could be unblinded in March at the earliest.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    27